Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Exp Cell Res
; 406(1): 112755, 2021 09 01.
Article
in En
| MEDLINE
| ID: mdl-34332981
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Resistance, Neoplasm
/
MAP Kinase Kinase 4
/
Dichloroacetic Acid
/
Myeloid Cell Leukemia Sequence 1 Protein
/
Sorafenib
/
Liver Neoplasms
Type of study:
Prognostic_studies
Language:
En
Journal:
Exp Cell Res
Year:
2021
Type:
Article
Affiliation country:
China